See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2023_INTERCEPT_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001270073, INTERCEPT PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 540,127,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 987,000 |
| 3 | remainder_Assets | 12,597,000 |
| 4 | LiabilitiesCurrent | 230,077,000 |
| 5 | LiabilitiesNoncurrent | 230,557,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 984,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 176,303,000 |
| 9 | ResearchAndDevelopmentExpense | 176,639,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 285,710,000 |
| 12 | remainder_NetIncome | 290,032,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,383,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 553,711,000 |
| 1 | Liabilities | 460,634,000 |
| 2 | Expenses | 353,926,000 |
| 3 | Revenues | 285,710,000 |
| 4 | StockholdersEquity | 93,077,000 |
| 5 | NetIncome | 221,816,000 |
| 6 | ComprehensiveNetIncome | 219,124,500 |
| 7 | BaseVar | 974,698,000 |
| 8 | EconomicCapitalRatio | 0.748 |
Edgar->Model Mapping
Feature Distribution
Change over Time
